The SGLT2-inhibitor Empagliflozin Improves Parameters of Diastolic Function after Myocardial Infarction Measured by Echocardiography-a Single Center Sub Analysis of the EMMY-Trial

C. Strohhofer,S. Oltean, A. Huettmair, C. Pipp,M. Benedikt,M. Wallner,N. Verheyen,J. Gollmer,K. Ablasser, D. Hanfstingl-Sinz, J. Andorfer, S. Pachinger-Poessl, M. Brunner, J. Rogozarski,E. Kolesnik

WIENER KLINISCHE WOCHENSCHRIFT（2023）

Cited 0|Views21

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined